A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy
Authors:
- 25 February 2024
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 28 (6) , 539-546
Abstract
Background The effects of exercise therapy (ET) on renal function in chronic kidney disease (CKD) remain unclear. Methods In a randomized controlled trial (UMIN-CTR number: UMIN000038415), we investigated whether ET affects renal function in CKD; eligible patients had undergone renal biopsy in the past 3 months. We stratified patients by disease (immunoglobulin A [IgA] nephropathy, n = 16; diabetic nephropathy, n = 4; benign nephrosclerosis, n = 13; and other CKD types, n = 13) and randomized them to 12 weeks’ observation and 24 weeks’ ET comprising home-based aerobic exercise 3×/week and resistance training 2×/week (intervention group) or usual care (non-intervention group). Primary endpoint was creatinine-based estimated glomerular filtration rate (eGFR) or serum cystatin C-based eGFR (eGFRcys). Secondary endpoints included urinary protein and exercise tolerance. Results Seventy patients were enrolled, 50 fulfilled the inclusion criteria, but 4 discontinued before randomization. No items significantly differed between week 0 to 24 in either group (intervention group, n = 23; non-intervention group, n = 23) or between groups at week 24 (intention-to-treat population) in the total study population. The eGFRcys slope showed no significant intergroup difference in the observation period, but eGFRcys improved significantly in IgA nephropathy patients (n = 16) in the intervention group (stratified comparison; week 0, 48.3 ± 18.2; week 24, 51.6 ± 17.6; p = 0.043). In these patients, urinary protein was significantly worse at week 24 in the non-intervention group (p = 0.046) and worsened significantly less in the intervention group (p = 0.039). Conclusion ET did not improve renal function overall in CKD patients but might help maintain renal function in patients with IgA nephropathy.Keywords
This publication has 22 references indexed in Scilit:
- Measurement Properties of the Incremental Shuttle Walk TestChest, 2014
- GFR Estimation Using Standardized Serum Cystatin C in JapanAmerican Journal of Kidney Diseases, 2013
- Effects of exercise training on nitric oxide synthase in the kidney of spontaneously hypertensive ratsClinical and Experimental Pharmacology and Physiology, 2012
- Therapeutic action of physical exercise on markers of oxidative stress induced by chronic kidney diseaseLife Sciences, 2012
- Exercise training for adults with chronic kidney diseaseCochrane Database of Systematic Reviews, 2011
- Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2011
- Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA NephropathyClinical Journal of the American Society of Nephrology, 2011
- Effect of Exercise on Oxidative StressMedicine & Science in Sports & Exercise, 2010
- Oxidative Stress in IgA NephropathyNephron Clinical Practice, 2010
- Treatment allocation by minimisationBMJ, 2005